Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

Mashup Score: 5

UroToday

In this brief commentary, Charles Ryan highlights the phase 3, open-label PRESTO study, its importance, and its uniqueness being the first phase 3 study